Search Results - "Roselt, Peter D"

Refine Results
  1. 1

    Effective Preparation of [ 18 F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor by Haskali, Mohammad B, Roselt, Peter D, O'Brien, Terence J, Hutton, Craig A, Ali, Idrish, Vivash, Lucy, Jupp, Bianca

    Published in Molecules (Basel, Switzerland) (13-09-2022)
    “…(1) Background: [18F]Flumazenil 1 ([18F]FMZ) is an established positron emission tomography (PET) radiotracer for the imaging of the gamma-aminobutyric acid…”
    Get full text
    Journal Article
  2. 2

    Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE by Noor, Asif, Roselt, Peter D., McGowan, Emily R., Poniger, Stan, Wheatcroft, Michael P., Donnelly, Paul S.

    Published in EJNMMI radiopharmacy and chemistry (08-05-2024)
    “…Background Automated [ 89 Zr]Zr-radiolabeling processes have the potential to streamline the production of [ 89 Zr]Zr-labelled PET imaging agents. Most…”
    Get full text
    Journal Article
  3. 3

    Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform by Haskali, Mohammad B., Roselt, Peter D., Binns, David, Hetsron, Amit, Poniger, Stan, Hutton, Craig A., Hicks, Rodney J.

    Published in EJNMMI radiopharmacy and chemistry (23-08-2019)
    “…Background Gallium-68 ([ 68 Ga]Ga) labelled radiopharmaceuticals have become a valuable tool in clinical practice using Positron Emission Tomography (PET)…”
    Get full text
    Journal Article
  4. 4

    One-step radiosynthesis of 4-nitrophenyl 2-[18F]fluoropropionate ([18F]NFP); improved preparation of radiolabeled peptides for PET imaging by Haskali, Mohammad B., Roselt, Peter D., Karas, John A., Noonan, Wayne, Wichmann, Christian W., Katsifis, Andrew, Hicks, Rodney J., Hutton, Craig A.

    “…The versatile 18F‐labeled prosthetic group, 4‐nitrophenyl 2‐[18F]fluoropropionate ([18F]NFP), was synthesized in a single step in 45 min from 4‐nitrophenyl…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin‑2 Receptor Positive Cancers by Corlett, Alicia, Pinson, Jo-Anne, Rahimi, Marwa N., Zuylekom, Jessica Van, Cullinane, Carleen, Blyth, Benjamin, Thompson, Philip E., Hutton, Craig A., Roselt, Peter D., Haskali, Mohammad B.

    Published in Journal of medicinal chemistry (10-08-2023)
    “…Peptide receptor radionuclide therapy (PRRT) is a promising form of systemic radiation therapy designed to eradicate cancer. Cholecystokinin-2 receptor (CCK2R)…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Copper Bis(thiosemicarbazonato)-stilbenyl Complexes That Bind to Amyloid‑β Plaques by Noor, Asif, Hayne, David J, Lim, SinChun, Van Zuylekom, Jessica K, Cullinane, Carleen, Roselt, Peter D, McLean, Catriona A, White, Jonathan M, Donnelly, Paul S

    Published in Inorganic chemistry (17-08-2020)
    “…Alzheimer’s disease is characterized by the presence of extracellular amyloid-β plaques. Positron emission tomography (PET) imaging with tracers radiolabeled…”
    Get full text
    Journal Article
  10. 10

    Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups by Paterson, Brett M, Cullinane, Carleen, Crouch, Peter J, White, Anthony R, Barnham, Kevin J, Roselt, Peter D, Noonan, Wayne, Binns, David, Hicks, Rodney J, Donnelly, Paul S

    Published in Inorganic chemistry (01-04-2019)
    “…The synthesis of new bis­(thiosemicarbazonato)­copper­(II) complexes featuring polyamine substituents via selective transamination reactions is presented…”
    Get full text
    Journal Article
  11. 11

    Precision peptide theranostics: developing N - to C -terminus optimized theranostics targeting cholecystokinin-2 receptor by Rahimi, Marwa N, Corlett, Alicia, Van Zuylekom, Jessica, Sani, Marc Antoine, Blyth, Benjamin, Thompson, Philip, Roselt, Peter D, Haskali, Mohammad B

    Published in Theranostics (01-01-2024)
    “…Peptides are ideal for theranostic development as they afford rapid target accumulation, fast clearance from background tissue, and exhibit good tissue…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Gallium Fluoride Complexes with Acyclic Bispicolinic Ligands as Potential New Fluorine‐18 Labelled Imaging Agents by Koay, HuiJing, Haskali, Mohammad B., Roselt, Peter D., White, Jonathan M., Donnelly, Paul S.

    Published in European journal of inorganic chemistry (22-09-2020)
    “…The positron‐emitting radionuclide, fluorine‐18, is used to radiolabel molecules to develop tracers for diagnostic imaging with positron‐emission tomography…”
    Get full text
    Journal Article
  14. 14

    Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu by McInnes, Lachlan E, Cullinane, Carleen, Roselt, Peter D, Jackson, Susan, Blyth, Benjamin J, van Dam, Ellen M, Zia, Nicholas A, Harris, Matthew J, Hicks, Rodney J, Donnelly, Paul S

    Published in The Journal of nuclear medicine (1978) (01-06-2021)
    “…Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) is promising for prostate cancer. We previously reported a ligand, 64Cu-CuSarbisPSMA,…”
    Get full text
    Journal Article
  15. 15

    Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67 Cu by McInnes, Lachlan E, Cullinane, Carleen, Roselt, Peter D, Jackson, Susan, Blyth, Benjamin J, van Dam, Ellen M, Zia, Nicholas A, Harris, Matthew J, Hicks, Rodney J, Donnelly, Paul S

    Published in Journal of Nuclear Medicine (01-06-2021)
    “…Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) is promising for prostate cancer. We previously reported a ligand, Cu-CuSarbisPSMA,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules by Haskali, Mohammad B, Farnsworth, Ashleigh L, Roselt, Peter D, Hutton, Craig A

    Published in RSC medicinal chemistry (01-08-2020)
    “…Indirect radiolabelling has for a long time been the mainstay strategy for radiofluorination of biomolecules. Acylation of biomolecules through the use of an…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A Copper Complex of a Thiosemicarbazone-Pyridylhydrazone Ligand Containing a Vinylpyridine Functional Group as a Potential Imaging Agent for Amyloid-β Plaques by McInnes, Lachlan E, Noor, Asif, Roselt, Peter D, McLean, Catriona A, White, Jonathan M, Donnelly, Paul S

    Published in Critical studies in media communication (01-01-2019)
    “…Complexes containing positron-emitting radionuclides of copper have the potential to be of use for diagnostic imaging with positron emission tomography…”
    Get full text
    Journal Article
  20. 20

    Radiosynthesis and preliminary in vivo evaluation of 18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis by Haskali, Mohammad B, Denoyer, Delphine, Roselt, Peter D, Hicks, Rodney J, Hutton, Craig A

    Published in MedChemComm (01-11-2019)
    “…Duramycin derivatives incorporating an [18F]-labelled prosthetic group and one or two hydrophilic sugar amino acid moieties have been prepared as potential…”
    Get full text
    Journal Article